GLAXOSMITHKLINE PHARMACEUTICALS LTD.
BSE: 500660
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.2K+27.6% | 924.42-6.5% | 989.15-3.3% | 1.0K+5.0% | 973.63+21.0% | 804.83-16.7% | 966.08+2.1% | 946.36 |
| Other Income | 72.77+18.1% | 61.63+72.6% | 35.71+12.2% | 31.82+1.8% | 31.27-28.5% | 43.76+10.9% | 39.46+12.5% | 35.06 |
| Total Income | 1.3K+27.0% | 986.05-3.8% | 1.0K-2.8% | 1.1K+4.9% | 1.0K+18.4% | 848.59-15.6% | 1.0K+2.5% | 981.42 |
| EXPENSES | ||||||||
| Expenditure | 795.10+22.7% | 648.07-1.2% | 655.74-3.1% | 676.52+3.0% | 656.89+15.2% | 570.02-12.4% | 650.64-3.6% | 675.07 |
| Tax | 122.96+45.3% | 84.65-10.1% | 94.18-6.5% | 100.71+5.3% | 95.65+29.5% | 73.87-22.0% | 94.76+21.8% | 77.77 |
| PROFIT | ||||||||
| PBT | 457.58+35.4% | 337.98-8.4% | 369.12-2.3% | 377.89+7.8% | 350.65+25.9% | 278.57-21.5% | 354.90+15.8% | 306.35 |
| Net Profit | 334.62+32.1% | 253.33-7.9% | 274.94-0.8% | 277.18+8.7% | 255.00+24.6% | 204.70-21.3% | 260.14+13.8% | 228.58 |
| KEY METRICS | ||||||||
| OPM % | 33.93%+2.22pp | 31.71%-3.39pp | 35.10%-0.85pp | 35.95%+1.30pp | 34.65%+3.49pp | 31.16%-3.08pp | 34.24%+7.57pp | 26.67% |
| NPM % | 26.71%+1.02pp | 25.69%-1.14pp | 26.83%+0.54pp | 26.29%+0.91pp | 25.38%+1.26pp | 24.12%-1.75pp | 25.87%+2.58pp | 23.29% |
| EPS | 19.76+32.2% | 14.95-7.9% | 16.23-0.8% | 16.36+9.7% | 14.92+23.5% | 12.08-21.3% | 15.35+13.8% | 13.49 |
Corporate Events
Board MeetingGLAXO
20263Nov
Board Meeting
The Board of Directors meeting is scheduled to consider, app…
BSE Filing ↗ Board MeetingGLAXO
20263Aug
Board Meeting
A meeting of the Board of Directors of our Company will be h…
BSE Filing ↗ Board MeetingGLAXO
20251Aug
Board Meeting
Board Meeting Intimation, Un-Audited Financial Results for t…
BSE Filing ↗ Board MeetingGLAXO
202514Feb
Board Meeting
Consider and approve Un-audited financial results for the th…
BSE Filing ↗ Board MeetingGLAXO
202429Oct
Board Meeting
consider and approve Unaudited financial results for the sec…
BSE Filing ↗ Board MeetingGLAXO
20242Aug
Board Meeting
Consider and approve Un-Audited Financial Results for the fi…
BSE Filing ↗ Board MeetingGLAXO
202412Feb
Board Meeting
consider and approve Un-Audited Financial Results for the th…
BSE Filing ↗ Board MeetingGLAXO
20239Nov
Board Meeting
Consideration and approval of Un-Audited Financial Results f…
BSE Filing ↗